CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 52 filers reported holding CASI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $104,000 | -36.2% | 87,500 | -16.8% | 0.00% | – |
| Q2 2021 | $163,000 | -56.3% | 105,200 | -32.3% | 0.00% | – |
| Q1 2021 | $373,000 | +12.0% | 155,288 | +37.5% | 0.00% | – |
| Q4 2020 | $333,000 | +197.3% | 112,917 | +53.7% | 0.00% | – |
| Q3 2020 | $112,000 | -39.1% | 73,477 | 0.0% | 0.00% | – |
| Q2 2020 | $184,000 | +23.5% | 73,477 | +0.7% | 0.00% | – |
| Q1 2020 | $149,000 | -33.8% | 72,976 | 0.0% | 0.00% | – |
| Q4 2019 | $225,000 | -5.1% | 72,976 | +2.8% | 0.00% | – |
| Q3 2019 | $237,000 | +4.9% | 70,978 | +0.4% | 0.00% | – |
| Q2 2019 | $226,000 | +11.3% | 70,674 | +0.1% | 0.00% | – |
| Q1 2019 | $203,000 | -28.3% | 70,574 | +0.1% | 0.00% | – |
| Q4 2018 | $283,000 | +20.9% | 70,474 | +40.9% | 0.00% | – |
| Q3 2018 | $234,000 | -42.8% | 50,012 | +0.6% | 0.00% | – |
| Q2 2018 | $409,000 | +98.5% | 49,733 | +0.7% | 0.00% | – |
| Q1 2018 | $206,000 | +25.6% | 49,400 | -2.0% | 0.00% | – |
| Q4 2017 | $164,000 | – | 50,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |